{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:21:47Z","timestamp":1791235307905,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.autrev.2021.102901","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T12:47:33Z","timestamp":1626439653000},"page":"102901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"20","author":[{"given":"Isabel Johanna","family":"Walter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirthe Jasmijn","family":"Klein Haneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Titia","family":"Lely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina Wilhelmina Maria","family":"Bloemenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Limper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Kooiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102901_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2021.102901_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","article-title":"Diagnosis and classification of the antiphospholipid syndrome","volume":"48\u201349","author":"G\u00f3mez-Puerta","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102901_bb0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102901_bb0020","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid s yndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102901_bb0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1034\/j.1600-0897.2001.d01-13.x","article-title":"Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis","volume":"46","author":"Carmona","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2021.102901_bb0030","first-page":"525","article-title":"Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study","volume":"216","author":"Saccone","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2021.102901_bb0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood-2013-08-522623","article-title":"Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study","volume":"123","author":"Bouvier","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102901_bb0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.autrev.2018.12.006","article-title":"The European registry on obstetric antiphospholipid syndrome (EUROAPS): a survey of 1000 consecutive cases","volume":"18","author":"Alijotas-Reig","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102901_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.autrev.2014.12.010","article-title":"The European registry on obstetric antiphospholipid syndrome (EUROAPS): a survey of 247 consecutive cases","volume":"14","author":"Alijotas-Reig","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102901_bb0050","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0961203317692432","article-title":"Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile","volume":"26","author":"Latino","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102901_bb0055","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.3109\/14767058.2016.1152254","article-title":"Maternal and fetal outcome in women with antiphospholipid syndrome: a three-year observational study","volume":"29","author":"Rezk","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.autrev.2021.102901_bb0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acr.20098","article-title":"Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome","volume":"62","author":"Ruffatti","year":"2010","journal-title":"Arthritis Care Res Hoboken"},{"key":"10.1016\/j.autrev.2021.102901_bb0065","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1586\/1744666X.2014.968129","article-title":"Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome","volume":"10","author":"Chighizola","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2021.102901_bb0070","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.autrev.2018.03.018","article-title":"Antiphospholipid syndrome: an update on risk factors for pregnancy outcome","volume":"17","author":"De Carolis","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102901_bb0075","doi-asserted-by":"crossref","DOI":"10.4172\/2155-6121.1000239","article-title":"Predictors of pregnancy outcome in antiphospholipid syndrome: a review","volume":"7","author":"Tabacco","year":"2016","journal-title":"J Allergy Ther"},{"key":"10.1016\/j.autrev.2021.102901_bb0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jri.2017.08.001","article-title":"Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: a multicenter study","volume":"122","author":"Deguchi","year":"2017","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.autrev.2021.102901_bb0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jamia.2001.0080391","article-title":"Searching for clinical prediction rules in medline","volume":"8","author":"Ingui","year":"2001","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.autrev.2021.102901_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/96bdb520-d704-45f0-a143-43a48552952e","article-title":"Search filters for finding prognostic and diagnostic prediction studies in medline to enhance systematic reviews","volume":"7","author":"Geersing","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.autrev.2021.102901_bb0095","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102901_bb0100","article-title":"A guide to systematic review and meta-analysis of prognostic factor studies","volume":"364","author":"Riley","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2021.102901_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2021.102901_bb0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2021.102901_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/jrsm.1460","article-title":"Zero-cell corrections in random-effects meta-analyses","author":"Weber","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.autrev.2021.102901_bb0120","series-title":"Cochrane handbook for systematic reviews of interventions. Version 6.1 (updated September 2020)","year":"2020"},{"key":"10.1016\/j.autrev.2021.102901_bb0125","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.autrev.2021.102901_bb0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2021.102901_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jth.14633","article-title":"The (non-)sense of detecting anti-cardiolipin and anti-\u03b22glycoprotein I IgM antibodies in the antiphospholipid syndrome","volume":"18","author":"Chayoua","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2021.102901_bb0140","series-title":"Doing Meta-analysis in R: A Hands-on Guide","author":"Harrer","year":"2019"},{"key":"10.1016\/j.autrev.2021.102901_bb0145","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2020"},{"key":"10.1016\/j.autrev.2021.102901_bb0150","series-title":"dmetar: Companion R Package For The Guide \u201cDoing Meta-analysis in R\u201d","author":"Harrer","year":"2019"},{"key":"10.1016\/j.autrev.2021.102901_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.autrev.2021.102901_bb0160","first-page":"131","article-title":"A study of sixty pregnancies in patients with the antiphospholipid syndrome","volume":"14","author":"Lima","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.102901_bb0165","article-title":"Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study","author":"Li","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102901_bb0170","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/0961203319852155","article-title":"Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile","volume":"28","author":"H\u00f6gd\u00e9n","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102901_bb0175","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.thromres.2008.03.012","article-title":"Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy","volume":"123","author":"Ruffatti","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2021.102901_bb0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1160\/TH06-05-0287","article-title":"Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity","volume":"96","author":"Ruffatti","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2021.102901_bb0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","article-title":"Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome","volume":"19","author":"Bramham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102901_bb0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ijgo.12511","article-title":"Antiphospholipid syndrome characteristics and adverse pregnancy outcomes after 20 weeks of pregnancy","volume":"142","author":"Gabbay-Benziv","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.autrev.2021.102901_bb0195","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1538-7836.2010.03747.x","article-title":"Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies","volume":"8","author":"Chauleur","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2021.102901_bb0200","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3389\/fimmu.2018.00864","article-title":"Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: results from a multicenter study of 283 pregnancies","volume":"9","author":"Fredi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102901_bb0205","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2021.102901_bb0210","first-page":"2025","article-title":"A study of 75 pregnancies in patients with antiphospholipid syndrome","volume":"28","author":"Huong","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102901_bb0215","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102901_bb0220","first-page":"17103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Prim"},{"key":"10.1016\/j.autrev.2021.102901_bb0225","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.autrev.2015.01.008","article-title":"Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature","volume":"14","author":"Viall","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102901_bb0230","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0961203309361351","article-title":"Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view","volume":"19","author":"Meroni","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102901_bb0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41584-018-0032-6","article-title":"Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?","volume":"14","author":"Meroni","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102901_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-015-0133-7","article-title":"The CROWN initiative: journal editors invite researchers to develop core outcomes in women\u2019s health","volume":"8","author":"Khan","year":"2015","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.autrev.2021.102901_bb0245","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American College of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102901_bb0250","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2018","author":"Bender Atik","year":"2018","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.autrev.2021.102901_bb0255","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.autrev.2021.102901_bb0260","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/aji.12534","article-title":"Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European registry on obstetric antiphospholipid syndrome cohort","volume":"76","author":"Alijotas-Reig","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2021.102901_bb0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/JPM.1999.025","article-title":"Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome","volume":"27","author":"Brewster","year":"1999","journal-title":"J Perinat Med"},{"key":"10.1016\/j.autrev.2021.102901_bb0270","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3899\/jrheum.170751","article-title":"Antiphosphatidylserine\/prothrombin antibodies in antiphospholipid syndrome with intrauterine growth restriction and preeclampsia","volume":"45","author":"Canti","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102901_bb0275","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-0897.2004.00215.x","article-title":"Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters","volume":"52","author":"De Carolis","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2021.102901_bb0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s004040100179","article-title":"A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome","volume":"266","author":"Diejomaoh","year":"2002","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.autrev.2021.102901_bb0285","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12026-018-9024-5","article-title":"What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?","volume":"66","author":"Latino","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2021.102901_bb0290","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/aogs.12038","article-title":"Anti-\u03b22 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome","volume":"92","author":"Liu","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.autrev.2021.102901_bb0295","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1600-0412.2011.01236.x","article-title":"High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome","volume":"90","author":"Simchen","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.autrev.2021.102901_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221001749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221001749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:23:16Z","timestamp":1761600196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221001749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1568997221001749"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102901","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102901"}}